ATC code J06
| ATC code J: Antiinfectives for systemic use |
|---|
|
| Human only |
| ATCvet only |
|
| Other ATC codes |
ATC code J06 Immune sera and immunoglobulins is a therapeutic subgroup of the Anatomical Therapeutic Chemical Classification System, a system of alphanumeric codes developed by the World Health Organization (WHO) for the classification of drugs and other medical products.[1][2][3] Subgroup J06 is part of the anatomical group J Antiinfectives for systemic use.[4]
National issues of the ATC classification may include additional codes not present in this list, which follows the WHO version.
J06A Immune sera[edit]
J06AA Immune sera[edit]
- J06AA01 Diphtheria antitoxin
- J06AA02 Tetanus antitoxin
- J06AA03 Snake venom antiserum
- J06AA04 Botulinum antitoxin
- J06AA05 Gas-gangrene sera
- J06AA06 Rabies serum
J06B Immunoglobulins[edit]
J06BA Immunoglobulins, normal human[edit]
- J06BA01 Immunoglobulins, normal human, for extravascular administration
- J06BA02 Immunoglobulins, normal human, for intravascular administration
J06BB Specific immunoglobulins[edit]
- J06BB01 Anti-D (rh) immunoglobulin
- J06BB02 Tetanus immunoglobulin
- J06BB03 Varicella/zoster immunoglobulin
- J06BB04 Hepatitis B immunoglobulin
- J06BB05 Rabies immunoglobulin
- J06BB06 Rubella immunoglobulin
- J06BB07 Vaccinia immunoglobulin
- J06BB08 Staphylococcus immunoglobulin
- J06BB09 Cytomegalovirus immunoglobulin
- J06BB10 Diphtheria immunoglobulin
- J06BB11 Hepatitis A immunoglobulin
- J06BB12 Encephalitis, tick-borne immunoglobulin
- J06BB13 Pertussis immunoglobulin
- J06BB14 Morbilli immunoglobulin
- J06BB15 Parotitis immunoglobulin
- J06BB19 Anthrax immunoglobulin
- J06BB30 Combinations
J06BC Antibacterial monoclonal antibodies[edit]
- J06BC01 Nebacumab
- J06BC02 Raxibacumab
- J06BC03 Bezlotoxumab
- J06BC04 Obiltoxaximab
J06BD Antiviral monoclonal antibodies[edit]
- J06BD01 Palivizumab
- J06BD02 Motavizumab
- J06BD03 Tixagevimab and cilgavimab
- J06BD04 Ansuvimab
- J06BD05 Sotrovimab
- J06BD06 Regdanvimab
- J06BD07 Casirivimab and imdevimab
- J06BD08 Nirsevimab
See also[edit]
References[edit]
- ^ "ATC (Anatomical Therapeutic Chemical Classification System) – Synopsis". National Institutes of Health. Retrieved 1 February 2020.
- ^ World Health Organization. "Anatomical Therapeutic Chemical (ATC) Classification". World Health Organization. Retrieved 3 January 2022.
- ^ "Structure and principles". WHO Collaborating Centre for Drug Statistics Methodology. 15 February 2018. Retrieved 3 January 2022.
- ^ "ATC/DDD Index 2022: code J06". WHO Collaborating Centre for Drug Statistics Methodology.